Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: A long-term study in Japan

Journal of Medical Microbiology

Volumn 62, Issue PART7, 2013, Pages 1038-1043

  Chong, Yong ^a   Shimoda, Shinji ^a   Yakushiji, Hiroko ^b   Ito, Yoshikiyo ^b   Miyamoto, Toshihiro ^a   Kamimura, Tomohiko ^b   Shimono, Nobuyuki ^c   Akashi, Koichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; COMMUNITY ACQUIRED INFECTION; ESCHERICHIA COLI; GENOTYPE; HOSPITAL PATIENT; HUMAN; JAPAN; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; PROTEUS MIRABILIS;

BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; JAPAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PREVALENCE; PROTEUS INFECTIONS; PROTEUS MIRABILIS; TIME FACTORS;

EID: 84879159262     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.059279-0     Document Type: Article

References (34)

1. Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A. & Carmeli, Y. (2006). Influx of extended-spectrum b-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42, 925-934.
2. Bonnet, R. (2004). Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
3. Calbo, E., Freixas, N., Xercavins, M., Riera, M., Nicolás, C., Monistrol, O., Solé, M. M., Sala, M. R., Vila, J. & Garau, J. (2011). Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin Infect Dis 52, 743-749.
4. Cantón, R. & Coque, T. M. (2006). The CTX-M b-lactamase pandemic. Curr Opin Microbiol 9, 466-475.
5. Chong, Y., Yakushiji, H., Ito, Y. & Kamimura, T. (2011). Clinical and molecular epidemiology of extended-spectrum b-lactamase-pro-ducing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 30, 83-87.
6. Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M. & Karageorgopoulos, D. E. (2010). Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum b-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10, 43-50.
7. Hansen, D. S., Schumacher, H., Hansen, F., Stegger, M., Hertz, F. B., Schønning, K., Justesen, U. S., Frimodt-Møller, N. & DANRES Study Group (2012). Extended-spectrum b-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, b-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis 44, 174-181.
8. Hawkey, P. M. (2008). Prevalence and clonality of extended-spectrum b-lactamases in Asia. Clin Microbiol Infect 14 (Suppl. 1), 159-165.
9. Ishii, Y., Ohno, A., Taguchi, H., Imajo, S., Ishiguro, M. & Matsuzawa, H. (1995). Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39, 2269-2275.
10. Jacoby, G. A. & Munoz-Price, L. S. (2005). The new beta-lactamases. N Engl J Med 352, 380-391.
11. Khanna, N., Boyes, J., Lansdell, P. M., Hamouda, A. & Amyes, S. G. (2012). Molecular epidemiology and antimicrobial resistance pattern of extended-spectrum-b-lactamase-producing Enterobacteriaceae in Glasgow, Scotland. J Antimicrob Chemother 67, 573-577.
12. Lee, J. A., Kang, C. I., Joo, E. J., Ha, Y. E., Kang, S. J., Park, S. Y., Chung, D. R., Peck, K. R., Ko, K. S. & other authors (2011). Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum b-lactamase-producing Klebsiella pneu-moniae. Microb Drug Resist 17, 267-273.
13. Luvsansharav, U. O., Hirai, I., Niki, M., Nakata, A., Yoshinaga, A., Moriyama, T. & Yamamoto, Y. (2011). Prevalence of fecal carriage of extended-spectrum b-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 17, 722-725.
14. Luzzaro, F., Mezzatesta, M., Mugnaioli, C., Perilli, M., Stefani, S., Amicosante, G., Rossolini, G. M. & Toniolo, A. (2006). Trends in production of extended-spectrum b-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44, 1659-1664.
15. Muratani, T., Kobayashi, T. & Matsumoto, T. (2006). Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int J Antimicrob Agents 27, 491-499.
16. Oteo, J., Orden, B., Bautista, V., Cuevas, O., Arroyo, M., Martínez-Ruiz, R., Pérez-Vázquez, M., Alcaraz, M., García-Cobos, S. & Campos, J. (2009). CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin. J Antimicrob Chemother 64, 712-717.
17. Oteo, J., Pérez-Vázquez, M. & Campos, J. (2010). Extended-spectrum b-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23, 320-326.
18. Paterson, D. L. & Bonomo, R. A. (2005). Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 18, 657-686.
19. Peirano, G. & Pitout, J. D. (2010). Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25: H4. Int J Antimicrob Agents 35, 316-321.
20. Pitout, J. D. & Laupland, K. B. (2008). Extended-spectrum b-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8, 159-166.
21. Reinert, R. R., Low, D. E., Rossi, F., Zhang, X., Wattal, C. & Dowzicky, M. J. (2007). Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60, 1018-1029.
22. Rodríguez-Baño, J., Navarro, M. D., Romero, L., Muniain, M. A., de Cueto, M., Ríos, M. J., Herná ndez, J. R. & Pascual, A. (2006). Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 43, 1407-1414.
23. Rodríguez-Baño, J., Picón, E., Gijón, P., Hernández, J. R., Ruíz, M., Peña, C., Almela, M., Almirante, B., Grill, F. & other authors (2010). Community-onset bacteremia due to extended-spectrum b-lacta-mase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50, 40-48.
24. Rossi, F., Baquero, F., Hsueh, P. R., Paterson, D. L., Bochicchio, G. V., Snyder, T. A., Satishchandran, V., McCarroll, K., DiNubile, M. J. & Chow, J. W. (2006). In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (study for monitoring antimicrobial resistance trends). J Antimicrob Chemother 58, 205-210.
25. Roux, D., Huy, C., Lolom, I., Andremont, A., Arlet, G., Armand-Lefevre, L. & Lucet, J. C. (2012). Diversity of extended-spectrum b-lactamase-producing Enterobacteriaceae on hospital admission. Scand J Infect Dis 44, 231-236.
26. Shibata, N., Kurokawa, H., Doi, Y., Yagi, T., Yamane, K., Wachino, J., Suzuki, S., Kimura, K., Ishikawa, S. & other authors (2006). PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 50, 791-795.
27. Soge, O. O., Queenan, A. M., Ojo, K. K., Adeniyi, B. A. & Roberts, M. C. (2006). CTX-M-15 extended-spectrum b-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 57, 24-30.
28. Suzuki, S., Shibata, N., Yamane, K., Wachino, J., Ito, K. & Arakawa, Y. (2009). Change in the prevalence of extended-spectrum-b-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63, 72-79.
29. Talbot, G. H., Bradley, J., Edwards, J. E., Jr, Gilbert, D., Scheld, M., Bartlett, J. G. & Antimicrobial Availability Task Force of the Infectious Diseases Society of America (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42, 657-668.
30. Tumbarello, M., Trecarichi, E. M., Bassetti, M., De Rosa, F. G., Spanu, T., Di Meco, E., Losito, A. R., Parisini, A., Pagani, N. & Cauda, R. (2011). Identifying patients harboring extended-spectrum-b-lacta-mase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 55, 3485-3490.
31. Valverde, A., Coque, T. M., García-San Miguel, L., Baquero, F. & Cantón, R. (2008). Complex molecular epidemiology of extended-spectrum b-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J Antimicrob Chemother 61, 64-72.
32. Woerther, P. L., Angebault, C., Lescat, M., Ruppé, E., Skurnik, D., Mniai, A. E., Clermont, O., Jacquier, H., Costa, A. D. & other authors (2010). Emergence and dissemination of extended-spectrum b-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 202, 515-523.
33. Woerther, P. L., Angebault, C., Jacquier, H., Hugede, H. C., Janssens, A. C., Sayadi, S., El Mniai, A., Armand-Lefèvre, L., Ruppé, E. & other authors (2011). Massive increase, spread, and exchange of extended spectrum b-lactamase-encoding genes among intestinal Enterobac-teriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 53, 677-685.
34. Yamaguchi, K., Ishii, Y., Iwata, M., Watanabe, N., Shinagawa, M., Yasujima, M., Suwabe, A., Kuroda, M., Kaku, M. & other authors (2011). Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009. Jpn J Antibiot 64, 53-95 (in Japanese).